400037 重庆,陆军军医大学(第三军医大学)第二附属医院心血管内科
Received:25 July 2023,
Revised:2023-08-18,
Published:30 October 2023
移动端阅览
Gaoshan LI, Wenxu PAN, Zhichun GAO, et al. Risk factors for TEVAR-related post-implantation syndrome in Stanford type B aortic dissection patients[J]. Journal of Army Medical University, 2023, 45(20): 2149-2158.
Gaoshan LI, Wenxu PAN, Zhichun GAO, et al. Risk factors for TEVAR-related post-implantation syndrome in Stanford type B aortic dissection patients[J]. Journal of Army Medical University, 2023, 45(20): 2149-2158. DOI: 10.16016/j.2097-0927.202307091.
目的
2
探讨Stanford B型主动脉夹层(type B aortic dissection,TBAD)患者接受胸主动脉腔内修复术(thoracic endovascular aortic repair,TEVAR)后发生植入后综合征(post-implantation syndrome,PIS)的危险因素以及PIS与短期预后的关联。
方法
2
采用病例-对照研究设计方案,筛选2013年12月至2022年12月于我科接受TEVAR治疗TBAD患者的临床资料。根据患者术后是否发生PIS分为两组,探索影响PIS的独立相关因素。观察两组患者术后30天内全因死亡情况,绘制Kaplan-Meier生存曲线评估两组患者的术后30天生存情况,建立Logistic回归模型探索PIS与TEVAR术后30天全因死亡的关联。
结果
2
研究纳入373名TBAD患者,年龄(57.9±12.1)岁,其中男性289例(77.5%)。TEVAR术后发生PIS 106例(28.4%)。PIS组患者植入支架数量≥2个、手术时长≥2 h和植入聚对苯二甲酸乙二醇酯(polyethylene terephthalate
PET)覆膜材料支架的患者比例均显著高于非PIS组(
P
<
0.05)。多因素Logistic回归分析结果提示植入支架数≥2个(
OR
=1.886
95%
CI
:1.049~3.389
P
=0.034)、手术时长≥2 h(
OR
=1.938
95%
CI
:1.147~3.275
P
=0.013)和植入PET覆膜材料支架(
OR
=2.131,95%
CI
:1.263~3.597,
P
=0.005)是TEVAR术后发生PIS的独立危险因素。TEVAR术后30天内共发生死亡15例(4.0%),其中PIS组10例(9.4%),非PIS组5例(1.9%)。Kaplan-Meier曲线显示PIS组术后30天的生存曲线显著低于非PIS组(Log-rank
P
=0.000 7)。多因素Logistic回归模型显示胱抑素C(
OR
=1.486,95%
CI
:1.053~2.097,
P
=0.024)和PIS(
OR
=5.628
95%
CI
:1.836~17.248
P
=0.002)是TBAD患者TEAVR术后30天内死亡的独立危险因素。
结论
2
植入支架数≥2、手术时长≥2 h和植入PET覆膜材料支架与TEVAR术后发生PIS密切相关;而胱抑素C和术后发生PIS是TEVAR术后30天预后不良的重要危险因素。
Objective
2
To investigate the risk factors associated with post-implantation syndrome (PIS) in Stanford type B aortic dissection (TBAD) patients undergoing thoracic endovascular aortic repair (TEVAR) and the relationship of PIS with short-term outcomes.
Methods
2
A case-control trial was conducted on the clinical data of patients undergoing TEVAR treatment for TBAD in our department from December 2013 to December 2022. They were divided into 2 groups based on the occurrence of PIS. Independent risk factors were analyzed according to the different clinical characteristics between the 2 groups. The overall 30-day mortality following TEVAR was assessed in both groups. Kaplan-Meier survival curves were utilized to evaluate the 30-day postoperative survival. Logistic regression models were constructed to investigate the relationship between PIS and overall mortality occurring within 30 d after TEVAR.
Results
2
A total of 373 TBAD patients
with an average age of 57.9±12.1 years and a male ratio of 77.5% (289 cases)
were enrolled in this study. There were 106 cases (28.4%) experiencing PIS following TEVAR. Significantly larger proportions of implanted stents ≥2
operation duration ≥2 h and implantation of polyethylene terephthalate (PET)-coverted stents were observed in the PIS group than the non-PIS group (
P
<
0.05). Multivariate logistic regression analysis suggested that implanted stents ≥2 (
OR
=1.886
95%
CI
: 1.049~3.389
P
=0.034)
operation duration ≥2 h (
OR
=1.938
95%
CI
: 1.147~3.275
P
=0.013) and implantation of PET-coverted stents (
OR
=2.131
95%
CI
: 1.263~3.597
P
=0.005) were independent risk factors for PIS after TEVAR. Within 30 d after TEVAR
15 (4.0%) cases dead
including 10 (9.4%) from the PIS group and 5 (1.9%) from the non-PIS group. Kaplan-Meier survival curve indicated a significantly lower survival in the PIS group (Log-rank
P
=0.000 7). The results of multivariate logistic regression model indicated that cystatin C (
OR
=1.486
95%
CI
: 1.053~2.097
P
=0.024) and PIS (
OR
=5.628
95%
CI
: 1.836~17.248
P
=0.002) were independent risk factors for 30-day mortality after TEVAR in TBAD patients.
Conclusion
2
Implanted stents ≥2
operation duration ≥2 h and implantation of PET-coverted stents are closely associated with the occurrence PIS in TBAD patients after TEVAR. Cystatin C level and PIS are primary risk factors for poor 30-day prognosis after TEVAR.
中华医学会外科学分会血管外科学组. Stanford B型主动脉夹层诊断和治疗中国专家共识(2022版)[J]. 中国血管外科杂志(电子版), 2022, 14(2): 119-130. DOI: 10.3969/j.issn.1674-7429.2022.02.007
Vascular Surgery Group of Chinese Society of Surgery. China expert consensus on diagnosis and treatment of stanford type B aortic dissection (2022 edition)[J]. Chin J Vasc Surg Electron Version, 2022, 14(2): 119-130. DOI: 10.3969/j.issn.1674-7429.2022.02.007
DAKE M D, KATO N, MITCHELL R S, et al . Endovascular stent-graft placement for the treatment of acute aortic dissection[J ] . N Engl J Med, 1999, 340(20): 1546-1552. DOI: 10.1056/nejm199905203402004.
NIENABER C A, KISCHE S, ROUSSEAU H, et al . Endovascular repair of type B aortic dissection: long-term results of the randomized investigation of stent grafts in aortic dissection trial[J ] . Circ Cardiovasc Interv, 2013, 6(4): 407-416. DOI: 10.1161/CIRCINTERVENTIONS.113.000463.
EGGEBRECHT H, NIENABER C A, NEUHÄUSER M, et al . Endovascular stent-graft placement in aortic dissection: a meta-analysis[J ] . Eur Heart J, 2006, 27(4): 489-498. DOI: 10.1093/eurheartj/ehi493.
VELÁZQUEZ O C, CARPENTER J P, BAUM R A, et al . Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms[J ] . Am J Surg, 1999, 178(3): 185-189. DOI: 10.1016/s0002-9610(99)00144-0.
ZHU H Q, ZHANG L, LIANG T P, et al . Elevated preoperative neutrophil-to-lymphocyte ratio predicts early adverse outcomes in uncomplicated type B aortic dissection undergoing TEVAR[J ] . BMC Cardiovasc Disord, 2021, 21(1): 1-9. DOI: 10.1186/s12872-021-01904-y.
YANG F, LIU J T, CHEN L F, et al . Impact of lymphocyte-related blood parameters on short- and long-term outcomes of patients undergoing thoracic endovascular aortic repair[J ] . Angiology, 2021, 72(10): 953-960. DOI: 10.1177/00033197211012514.
ARNAOUTOGLOU E, PAPAS N, MILIONIS H, et al . Post-implantation syndrome after endovascular repair of aortic a neurysms: need for postdischarge surveillance[J ] . Interact Cardiovasc Thorac Surg, 2010, 11(4): 449-454. DOI: 10.1510/icvts.2010.242628.
BALK R A. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today?[J]. Virulence, 2014, 5(1): 20-26. DOI: 10.4161/viru.27135.
SPANOS K, DRAKOU A, GIANNOUKAS A D. Should we consider nickel allergy a potential factor associated with peripheral stent patency?[J]. Vascular, 2015, 23(2): 220. DOI: 10.1177/1708538114565207.
WELT F G, TSO C, EDELMAN E R, et al . Leukocyte recruitment and expression of chemokines following different forms of vascular injury[J ] . Vasc Med, 2003, 8(1): 1-7. DOI: 10.1191/1358863x03vm462oa.
MORIKAGE N, ESATO K, ZENPO N, et al . Is endovascular treatment of abdominal aortic aneurysms less invasive regarding the biological responses?[J ] . Surg Today, 2000, 30(2): 142-146. DOI: 10.1007/PL00010062.
DAWSON J, COCKERILL G W, CHOKE E, et al . Aortic aneurysms secrete interleukin-6 into the circulation[J ] . J Vasc Surg, 2007, 45(2): 350-356. DOI: 10.1016/j.jvs.2006.09.049.
VOÛTE M T, BASTOS GONÇALVES F M, VAN DE LUIJTGAARDEN K M, et al . Stent graft composition plays a material role in the postimplantation syndrome[J ] . J Vasc Surg, 2012, 56(6): 1503-1509. DOI: 10.1016/j.jvs.2012.06.072.
GERASIMIDIS T, SFYROERAS G, TRELLOPOULOS G, et al . Impact of endograft material on the inflammatory response after elective endovascular abdominal aortic aneurysm repair[J ] . Angiology, 2005, 56(6): 743-753. DOI: 10.1177/000331970505600612.
ON A C, TSANG, . Nickel-related adverse reactions in the treatment of cerebral aneurysms: a literature review[J]. World Neurosurg, 2018, 115: 147-153. DOI: 10.1016/j.wneu.2018.04.073.
SWARTBOL P, TRUEDSSON L, NORGREN L. Adverse reactions during endovascular treatment of aortic aneurysms may be triggered by interleukin 6 release from the thrombotic content[J]. J Vasc Surg, 1998, 28(4): 664-668. DOI: 10.1016/S0741-5214(98)70092-8.
MOULAKAKIS K G, ALEPAKI M, SFYROERAS G S, et al . The impact of endograft type on inflammatory response after endovascular treatment of abdominal aortic aneurysm[J ] . J Vasc Surg, 2013, 57(3): 668-677. DOI: 10.1016/j.jvs.2012.09.034.
VIDEM V, ØDEGÅRD A, MYHRE H O. Iohexol-induced neutrophil myeloperoxidase release and activation upon contact with vascular stent-graft material: a mechanism contributing to the postimplantation syndrome?[J]. J Endovasc Ther, 2003, 10(5): 958-967. DOI: 10.1177/152660280301000520.
KORNOWSKI R, HONG M K, TIO F O, et al . In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia[J ] . J Am Coll Cardiol, 1998, 31(1): 224-230. DOI: 10.1016/s0735-1097(97)00450-6.
TORRADO J, BUCKLEY L, DURÁN A, et al . Restenosis, stent thrombosis, and bleeding complications: navigating between Scylla and Charybdis [J ] . J Am Coll Cardiol, 2018, 71(15): 1676-1695. DOI: 10.1016/j.jacc.2018.02.023..
WALTHER T, HAMM C W, SCHULER G, et al . Perioperative results and complications in 15, 964 transcatheter aortic valve replacements[J ] . J Am Coll Cardiol, 2015, 65(20): 2173-2180. DOI: 10.1016/j.jacc.2015.03.034.
VON SEGESSER L K, GEROSA G, BORGER M A, et al . Prevent ion and management of potential adverse events during transapical aortic valve replacement[J ] . J Heart Valve Dis, 2013, 22(3): 276-286.
LANGER S, MOMMERTZ G, KOEPPEL T A, et al . Surgical correction of failed thoracic endovascular aortic repair[J ] . J Vasc Surg, 2008, 47(6): 1195-1202. DOI: 10.1016/j.jvs.2008.01.003.
NEUHAUSER B, CZERMAK B V, FISH J, et al . Type A dissection following endovascular thoracic aortic stent-graft repair[J ] . J Endovascular Ther, 2005, 12(1): 74-81. DOI: 10.1583/04-1369.1.
SWARTBOL P, TRUEDSSON L, PRSSON H, et al . Tumor necrosis factor-alpha and interleukin-6 release from white blood cells induced by different graft materialsin vitro are affected by pentoxifylline and iloprost[J ] . J Biomed Mater Res, 1997, 36(3): 400-406. DOI: 10.1002/(sici)1097-4636(19970905)36:3400:aid-jbm15 > 3.0.co;2-h.
LEE J H, CHOI J H, KIM E J. Volume of mural thrombus plays a role in the elevation of inflammatory markers after endovascular aortic repair[J]. J Cardiothorac Surg, 2018, 13(1): 1-7. DOI: 10.1186/s13019-018-0712-y.
HANS S S, JAREUNPOON O, BALASUBRAMANI AM M, et al . Size and location of thrombus in intact and ruptured abdominal aortic aneurysms[J ] . J Vasc Surg, 2005, 41(4): 584-588. DOI: 10.1016/j.jvs.2005.01.004.
HAN K N, SHI D M, YANG L X, et al . Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention[J ] . Ann Med, 2022, 54(1): 1667-1677. DOI: 10.1080/07853890.2022.2083671.
XIA Y Y, XIA C L, WU L D, et al . Systemic immune inflammation index (SⅡ), system inflammation response index (SIRI) and risk of all-cause mortality and cardiovascular mortality: a 20-year follow-up cohort study of 42, 875 US adults[J ] . J Clin Med, 2023, 12(3): 1128. DOI: 10.3390/jcm12031128.
JIN Z Q, WU Q, CHEN S H, et al . The associations of two novel inflammation indexes, SⅡ and SIRI with the risks for cardiovascular diseases and all-cause mortality: a ten-year follow-up study in 85, 154 individuals[J ] . J Inflamm Res, 2021, 14: 131-140. DOI: 10.2147/JIR.S283835.
FAIZER R, DOMBROVSKIY V Y, VOGEL T R. Impact of hospital-acquired infection on long-term outcomes after endovascular and open abdominal aortic aneurysm repair[J]. Ann Vasc Surg, 2014, 28(4): 823-830. DOI: 10.1016/j.avsg.2013.06.028.
ARNAOUTOGLOU E, KOUVELOS G, PAPA N, et al . Prospective evaluation of postimplantation syndrome evolution on patient outcomes after endovascular aneurysm repair for abdominal aortic aneurysm[J ] . J Vasc Surg, 2016, 63(5): 1248-1255. DOI: 10.1016/j.jvs.2015.11.043.
GORLA R, ERBEL R, KAHLERT P, et al . Clinical features and prognostic value of stent-graft-induced post-implantation syndrome after thoracic endovascular aortic repair in patients with type B acute aortic syndromes[J ] . Eur J Cardiothorac Surg, 2016, 49(4): 1239-1247. DOI: 10.1093/ejcts/ezv355.
GORLA R, ERBEL R, KUEHL H, et al . Prognostic value of. 18F-fluorodeoxyglucose PET-CT imaging in acute aortic syndromes: comparison with serological biomarkers of inflammation[J ] . Int J Cardiovasc Imaging, 2015, 31(8): 1677-1685. DOI: 10.1007/s10554-015-0725-8.
HE R, GUO D, SUN W, et al . Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms[J ] . J Thorac Cardiovasc Surg, 2008, 136(4): 922-929. DOI: 10.1016/j.jtcvs.2007.12.063.
KIN K, MIYAGAWA S, FUKUSHIMA S, et al . Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm[J ] . J Am Heart Assoc, 2012, 1(5): e745. DOI: 10.1161/Jaha.112.000745.
WANG T, HE X W, LIU X T, et al . Weighted gene coexpression network analysis identifies FKBP11 as a key regulator in acute aortic dissection through a NF-kB dependent pathway[J ] . Front Physiol, 2017, 8: 1010. DOI: 10.3389/fphys.2017.01010.
VRSALOVIĆ M, VRSALOVIĆ PRESEČKI A. Admission C-reactive protein and outcomes in acute aortic dissection: a systematic review[J]. Croat Med J, 2019, 60(4): 309-315. DOI: 10.3325/cmj.2019.60.309.
FENG W Z, ZHOU J Q, YU G M, et al . Association of serum cystatin C levels with mortality in patients with acute type A aortic dissection[J ] . Oncotarget, 2017, 8(60): 101103-101111. DOI: 10.18632/oncotarget.20593.
WANG J, YANG B W, LIU M L, et al . Serum cystatin C is a potential predictor of short-term mortality and acute kidney injury in acute aortic dissection patients: a retrospective cohort study[J ] . J Thorac Dis, 2022, 14(8): 2977-2986. DOI: 10.21037/jtd-22-937.
王立伟, 杨晨, 吴冠, 等. 脑阻抗断层扫描在Stanford A型主动脉夹层术后脑卒中诊断中的应用[J]. 空军军医大学学报, 2023, 44(8): 739-743, 747. DOI: 10.13276/j.issn.2097-1656.2023.08.011.
WANG L W, YANG C, WU G, et al . Application of cerebral electrical impedance tomography in the diagnosis of stroke after Stanford type A aortic dissection operation[J ] . J Air Force Med Univ, 2023, 44(8): 739-743, 747. DOI: 10.13276/j.issn.2097-1656.2023.08.011.
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
